More stories

  • in

    Procter & Gamble earnings beat estimates as shoppers buy more household staples

    Procter & Gamble beat Wall Street’s estimates for its quarterly earnings and revenue.
    The company’s volume rose 1% in its fiscal second quarter as demand for household staples like toilet paper and cleaning products rose.
    P&G reiterated its fiscal 2025 forecast.

    Pepto Bismol made by Procter & Gamble is displayed on a grocery store shelf on July 28, 2023 in Greenbrae, California. 
    Justin Sullivan | Getty Images

    Procter & Gamble on Wednesday reported quarterly earnings and revenue that beat analysts’ expectations, thanks to growing demand for household staples like toilet paper and laundry products.
    Shares of the company rose 3% in premarket trading.

    Here’s what the company reported for the quarter ended Dec. 31 compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

    Earnings per share: $1.88 vs. $1.86 expected
    Revenue: $21.88 billion vs. $21.54 billion expected

    P&G reported fiscal second-quarter net income attributable to the company of $4.63 billion, or $1.88 per share, up from $3.47 billion, or $1.40 per share, a year earlier.
    Net sales rose 2% to $21.88 billion. The company’s organic revenue, which excludes currency changes and divestments, increased 3% in the quarter.
    P&G’s volume grew 1% during the period. The metric excludes pricing, which makes it a more accurate reflection of demand than sales. Like many consumer companies, P&G has seen weaker demand for its products after several years of price hikes.
    The company’s baby, feminine and family care division reported the biggest increase in volume, with a 4% jump. P&G credited its family care and feminine care brands, which include its Charmin, Puffs and Tampax products. But baby care organic sales slid by low-single digits, as fewer parents bought Pampers diapers.

    P&G’s grooming segment, which includes Gillette razors, saw volume rise 2% in the quarter. The company said innovation fueled the increase in volume.
    The company’s fabric and home care division reported a volume increase of 1%. The segment includes Tide, Swiffer and Cascade products.
    P&G’s health care segment, which includes Pepto Bismol and Oral-B products, reported flat volume.
    Only P&G’s beauty division posted shrinking volume for the quarter. The company said that volume for its hair care products declined in its Greater China market, and its skin care segment, which includes Olay products, saw global volume decrease. Overall, the company’s beauty division saw volume fall 1%.
    P&G also reiterated its fiscal 2025 forecast. It anticipates core net earnings per share in a range of $6.91 to $7.05 and revenue growth of 2% to 4%. More

  • in

    Netflix shares soar as company reports surging revenue, tops 300 million subscribers

    Netflix beat on the top and bottom lines for the fourth quarter and raised its 2025 revenue forecast.
    The company surpassed 300 million paid memberships during the quarter, adding a record 19 million subscribers.
    The fourth quarter was the last for which Netflix will report quarterly paid subscriber counts.

    Nurphoto | Nurphoto | Getty Images

    Shares of Netflix soared more than 14% Tuesday after the company posted fourth-quarter results that beat on the top and bottom lines.
    The company surpassed 300 million paid memberships during the quarter, adding a record 19 million subscribers. Netflix said the growth was driven by its content slate, improved product and typical fourth-quarter seasonality.

    The company also shared that including “extra member accounts,” its global audience is estimated to be exceed 700 million.
    “We really have built the business on variety and quality across countries, across regions, across genres and really focused year-round on having a very strong slate of programming for our members,” Netflix co-CEO Ted Sarandos said during an investor call.
    Here’s how Netflix performed for its most recent quarter, ended Dec. 31, compared with Wall Street estimates:

    Earnings per share: $4.27 vs. $4.20, according to LSEG
    Revenue: $10.25 billion vs. $10.11 billion, according to LSEG
    Paid memberships: 301.63 million vs. 290.9 million, according to StreetAccount

    Net income for the period was $1.87 billion, or $4.27 per share, up from $938 million, or $2.11 per share, during the same quarter a year earlier.
    Revenue in the fourth quarter jumped 16% year-over-year, reaching $10.25 billion, higher than the $10.11 billion Wall Street had predicted.

    For the full year 2025, Netflix raised its revenue expectations to a range of $43.5 billion to $44.5 billion, around $500 million higher than its previous forecast to reflects improved business fundamentals and the expected carryover benefit of its stronger-than-expected fourth quarter performance.
    The fourth quarter was the last for which Netflix will report quarterly paid subscriber counts, as previously announced. Instead, it will start reporting a bi-annual “engagement report” alongside its second- and fourth-quarter releases.
    The streamer on Tuesday touted the success of its fourth-quarter slate, which included the release of season 2 of the hit series “Squid Game” as well as live sporting events like the record-breaking Jake Paul and Mike Tyson boxing match and National Football League games on Christmas Day.
    “We are thrilled that some folks came in for the fight and some folks came in for the games, but they stuck around for ‘Squid Game’ and for ‘Carry On’ and for ‘Black Doves’ and for ‘Six Triple Eight’ … Nate Bargatze’s new comedy special,” Sarandos said. “All those things performed really well in the quarter and continue to in the days and weeks after the fight and after the games.
    “And what’s really been most encouraging is the retention behavior of those folks who did come in for those events look a lot like the folks who come in for all of our other big titles,” he said.
    This year, the company said it plans to improve its core business with more series and films, enhance its product experience and continue to grow its ads business. Netflix is expected to delve further into the live event space and games, as well.
    The company also has the return of “Strangers Things” and “Wednesday,” two of its biggest hits, ahead for 2025. Additionally, the streamer will release a collection of new films from top directors and actors including Daniel Craig and Rian Johnson’s third “Knives Out” film, a Russo Brothers project called “The Electric State” starring Millie Bobby Brown, “Happy Gilmore 2” with Adam Sandler and a new take on Frankenstein from Guillermo del Toro.
    “We’re fortunate that we don’t have distractions like managing declining linear networks and, with our focus and continued investment, we have good and improving product/market fit around the world,” the company said in its earnings report Tuesday.
    Netflix also announced it would raise prices on some streaming tiers between $1 and $2 per month.
    Netflix’s cheaper, ad-supported tiers accounted for more than 55% of sign-ups in countries where the option is offered, the company said. Netflix also noted that memberships on its ad-supported plans grew around 30% quarter-over-quarter.
    “We’re on track to reach sufficient scale for ads members in all of our ads countries in 2025,” the company said. “A top priority in 2025 is to improve our offering for advertisers so that we can substantially grow our advertising.” More

  • in

    Netflix to hike prices on standard and ad-supported streaming plans

    Netflix is increasing the cost of its streaming plans in the U.S., including the cheaper, ad-supported tier.
    The company said it will also hike most of its membership plans in Canada, Portugal and Argentina.
    The company reported fourth-quarter earnings on Tuesday.

    The word “Netflix” shines brightly at the presentation of the new season (3) of the Netflix series “Bridgerton” in the Flora.
    Rolf Vennenbernd | Picture Alliance | Getty Images

    Netflix is hiking the price of most of its U.S. plans.
    The streaming giant announced on Tuesday that its standard plan without commercials will increase from $15.49 a month to $17.99. Its cheaper, ad-supported plan, which was more recently introduced to attract more subscribers, will increase from $6.99 per month to $7.99.

    In addition, the monthly cost of Netflix’s premium plan will increase from $22.99 to $24.99.
    The company, which reported fourth-quarter earnings on Tuesday, said it will also raise prices in Canada, Portugal and Argentina.
    Consumers have been faced with numerous price hikes in recent years across major streaming services including Netflix and its competitors, including Disney’s apps and Warner Bros. Discovery’s Max. Streamers have increasingly turned to higher prices and ad-supported plans as they look to reach profitability.
    “When you’re going to ask for a price increase, you better make sure you have the goods and engagement to back it up,” said Netflix co-CEO Ted Sarandos during Tuesday’s investor call, noting upcoming series and movies to be released in 2025.
    During Tuesday’s call, co-CEO Greg Peters said that the recent price increases in international markets went “smoothly.”

    Netflix last increased the cost of its standard plan without ads in 2022, while its premium plan last saw a hike in 2023. Meanwhile in 2023 the company discontinued its cheapest basic ad-free option. While the plan is no longer available to new customers, Netflix did increase the cost of it later that year.
    Netflix had ditched the basic ad-free tier soon after it introduced its cheaper, ad-supported plan in November 2022 as a response to slowing subscriber growth at the time. In November, Netflix said it had reached 70 million global monthly active users on its ad plans. This is the first time Netflix has altered the price of the ad-supported plan.
    The company has also been enforcing a crackdown on password sharing in a push to get more customers paying for its service.
    As part of that change, Netflix has given subscribers the option to add “extra members” to their accounts. The streamer said Tuesday the cost of extra members on standard plans without commercials will rise from $7.99 per month to $8.99. The extra members on ad-supported plans won’t see a price change.
    The crackdown appears to be paying off: Netflix reported on Tuesday that it added a record 19 million paid memberships during the fourth quarter to surpass 300 million subscribers. More

  • in

    United Airlines’ first-quarter outlook outpaces estimates after profits surge to end 2024

    United Airlines forecast first-quarter adjusted earnings of 75 cents to $1.25 a share.
    The company will hold a conference call with analysts Wednesday at 10:30 a.m. ET.
    The carrier has been ramping up competition with Delta Air Lines for high-spending travelers.

    A United Airlines airplane proceeds to a runway at Newark Liberty International Airport in front of the skyline of lower Manhattan and One World Trade Center in New York City on December 4, 2024, in Newark, New Jersey. 
    Gary Hershorn | Corbis News | Getty Images

    United Airlines forecast first-quarter earnings that surpassed analysts’ estimates as the carrier seeks to grow earnings again in 2025 thanks to strong travel demand.
    The airline said Tuesday that it expects to earn an adjusted 75 cents to $1.25 in the first three months of the year, above the 54 cents analysts had expected, according to LSEG estimates.

    United’s stock is up more than 180% over the past 12 months as of Tuesday’s close, more than any other U.S. carrier. United shares were up more than 3% in extended trading after it released results.
    Here is what United reported for the fourth quarter compared with what Wall Street expected, based on estimates compiled by LSEG:

    Earnings per share: $3.26 adjusted vs. $3.00 expected
    Revenue: $14.70 billion vs. $14.47 billion expected

    For full-year 2025, United expects to grow adjusted earnings to $11.50 to $13.50, in line with expectations of about $12.82, according to LSEG.
    United and rival Delta have benefitted from strong demand for pricier seats like in business class, international travel and their massive loyalty programs. Delta’s CEO Ed Bastian earlier this month said he expects 2025 to be the carrier’s “best financial year in our history.”

    Read more CNBC airline news

    United reported a $985 million profit for the fourth quarter, up 64% over last year, on $14.70 billion in revenue, which was up about 8% from a year earlier. Adjusting for one-time items, United reported $3.26 a share for the fourth quarter, also ahead of expectations.
    Loyalty-program revenue, as well as international, domestic and basic economy-class revenue all rose from a year earlier and unit revenue, which measures pricing power, turned positive over the same quarter of 2023. More

  • in

    David Einhorn says we have reached the ‘Fartcoin’ stage of the market cycle

    “We have reached the ‘Fartcoin’ stage of the market cycle,” Einhorn wrote in an investor letter obtained by CNBC.
    “Other than trading and speculation, it serves no other obvious purpose and fulfills no need that is not served elsewhere,” he said.

    David Einhorn, President at Greenlight Capital, speaking at the 14th CNBC Delivery Alpha Investor Summit in New York City on Nov. 13th, 2024. 
    Adam Jeffery | CNBC

    Greenlight Capital’s David Einhorn thinks speculative behavior in the current bull market has ascended to a level beyond common sense.
    “We have reached the ‘Fartcoin’ stage of the market cycle,” Einhorn wrote in an investor letter obtained by CNBC. “Other than trading and speculation, it serves no other obvious purpose and fulfills no need that is not served elsewhere.”

    A crypto token called “fartcoin” exploded in popularity as the recent election of Donald Trump unleashed a storm of animal spirits on Main Street. The meme coin is now edging toward a $2 billion market value, surpassing many U.S.-listed companies.
    More meme coins have emerged since the inception of fartcoin. Trump launched $TRUMP, a meme coin built on the Solana platform. Its market cap over the weekend climbed past $14 billion. The coin at one point was down more than 20% over the past 24 hours, but it has since cut its losses to around 3%. Trump’s wife, Melania, also unveiled a coin.
    “Nothing stops the launch of many more tradable coins,” Einhorn said. “Perhaps we are leaving the Fartcoin stage of the market and entering the Trump (and Melania) memecoin stage. It’s anyone’s guess as to what will happen next, but it feels like it’s going to be wild.”
    Einhorn’s letter comes as investors drive equities higher, buoyed by expectations for lower taxes and deregulation from the second Trump administration. On Tuesday, the day after the inauguration, the Dow Jones Industrial Average rallied more than 400 points. The S&P 500 and Nasdaq Composite climbed 0.8% and 0.7%, respectively.
    Shorting leveraged bitcoin ETFs
    Greenlight took advantage of the craziness around crypto during the fourth quarter by betting against some popular exchage-traded funds linked indirectly to bitcoin.

    The two funds the firm focused on were the T-Rex 2X Long MSTR Daily Target ETF (MSTU) and the Defiance Daily Target 2X Long MSTR ETF (MSTX). Those funds use derivatives to try to achieve two times the daily returns of MicroStrategy, a software company that has turned itself into a bitcoin treasury vehicle in recent years.
    The funds have at times struggled to achieve that goal due to MicroStrategy’s volatility and little supply of the derivatives most easily used to get the leveraged returns.
    The letter said Greenlight took short positions against those funds during the quarter, partially offset by owning MicroStrategy stock in an arbitrage trade that was a “material winner.”

    Don’t miss these insights from CNBC PRO More

  • in

    Mortgage rates aren’t likely to fall any time soon — here’s why

    Rates on a 30-year fixed mortgage rose above 7% in the week ended Jan. 16, according to Freddie Mac data.
    Mortgage rates were below 3% as recently as late 2021.
    They are unlikely to fall below 6% until 2026, economists said. That’s partly due to investor worries tied to President Donald Trump’s policy agenda, they said.

    The Good Brigade | Digitalvision | Getty Images

    Mortgage rates have risen in recent months, even as the Federal Reserve has cut interest rates.
    While those opposing movements may seem counterintuitive, they’re due to market forces that seem unlikely to ease much in the near term, according to economists and other finance experts.

    That may leave prospective homebuyers with a tough choice. They can either delay their home purchase or forge ahead with current mortgage rates. The latter option is complicated by elevated home prices, experts said.
    “If what you’re hoping or wishing for is an interest rate at 4%, or housing prices to drop 20%, I personally don’t think either one of those things is remotely likely in the near term,” said Lee Baker, a certified financial planner based in Atlanta and a member of CNBC’s Financial Advisor Council.

    Mortgage rates at 7% mean a ‘dead’ market

    Rates for a 30-year fixed mortgage jumped above 7% during the week ended Jan. 16, according to Freddie Mac. They’ve risen gradually since late September, when they had touched a recent low near 6%.
    Current rates represent a bit of whiplash for consumers, who were paying less than 3% for a 30-year fixed mortgage as recently as November 2021, before the Fed raised borrowing costs sharply to tame high U.S. inflation.
    “Anything over 7%, the market is dead,” said Mark Zandi, chief economist at Moody’s. “No one is going to buy.”

    Mortgage rates need to get closer to 6% or below to “see the housing market come back to life,” he said.

    The financial calculus shows why: Consumers with a 30-year, $300,000 fixed mortgage at 5% would pay about $1,610 a month in principal and interest, according to a Bankrate analysis. They’d pay about $1,996 — roughly $400 more a month — at 7%, it said.
    Meanwhile, the Fed began cutting interest rates in September as inflation has throttled back. The central bank reduced its benchmark rate three times over that period, by a full percentage point.
    Despite that Fed policy shift, mortgage rates are unlikely to dip back to 6% until 2026, Zandi said. There are underlying forces that “won’t go away quickly,” he said.
    “It may very well be the case that mortgage rates push higher before they moderate,” Zandi said.

    Why have mortgage rates increased?

    The first thing to know: Mortgage rates are tied more closely to the yield on 10-year U.S. Treasury bonds than to the Fed’s benchmark interest rate, said Baker, the founder of Claris Financial Advisors.
    Those Treasury yields were about 4.6% as of Tuesday, up from about 3.6% in September.
    Investors who buy and sell Treasury bonds influence those yields. They appear to have risen in recent months as investors have gotten worried about the inflationary impact of President Donald Trump’s proposed policies, experts said.
    More from Personal Finance:What to expect from travel prices in 2025Trump’s second term may mean downfall of FDIC, CFPBHere’s how the child tax credit could change in 2025
    Policies like tariffs and mass deportations of immigrants are expected to increase inflation, if they come to pass, experts said. The Fed may lower borrowing costs more slowly if that happens — and potentially raise them again, experts said.
    Indeed, Fed officials recently cited “upside risks” to inflation because of the potential effects of changes to trade and immigration policy.
    Investors are also worried about how a large package of anticipated tax changes under the Trump administration might raise the federal deficit, Zandi said.

    There are other factors influencing Treasury yields, too.
    For example, the Fed has been reducing its holdings of Treasury bonds and mortgage securities via its quantitative tightening policy, while Chinese investors have “turned more circumspect” in their buying of Treasurys and Japanese investors are less interested as they can now get a return on their own bonds, Zandi said.
    Mortgage rates “probably won’t fall below 6% until 2026, assuming everything goes as expected,” said Joe Seydl, senior markets economist at J.P. Morgan Private Bank.

    The mortgage premium is historically high

    Grace Cary | Moment | Getty Images

    Lenders typically price mortgages at a premium over 10-year Treasury yields.
    That premium, also known as a “spread,” was about 1.7 percentage points from 1990 to 2019, on average, Seydl said.
    The current spread is about 2.4 percentage points — roughly 0.7 points higher than the historical average.
    There are a few reasons for the higher spread: For example, market volatility had made lenders more conservative in their mortgage underwriting, and that conservatism was exacerbated by the regional banking “shock” in 2023, which caused a “severe tightening of lending standards,” Seydl said.
    “All told, 2025 is likely to be another year where housing affordability remains severely challenged,” he said.
    That higher premium is “exacerbating the housing affordability challenge” for consumers, Seydl said.
    The typical homebuyer paid $406,100 for an existing home in November, up 5% from $387,800 a year earlier, according to the National Association of Realtors.

    What can consumers do?

    In the current housing and mortgage market, financial advisor Baker suggests consumers ask themselves: Is buying a home the right financial move for me right now? Or will I be a renter instead, at least for the foreseeable future?
    Those who want to buy a home should try to put down a “significant” down payment, to reduce the size of their mortgage and help it fit more easily in their monthly budget, Baker said.

    Don’t subject the savings for a down payment to the whims of the stock market, he said.
    “That’s not something you should gamble with in the market,” he said.
    Savers can still get a roughly 4% to 5% return from a money market fund, high-yield bank savings account or certificate of deposit, for example.
    Some consumers may also wish to get an adjustable rate mortgage instead of a fixed rate mortgage — an approach that may get consumers a better mortgage rate now but could saddle buyers with higher payments later due to fluctuating rates, Baker said.
    “You’re taking a gamble,” Baker said.
    He doesn’t recommend the approach for someone on a fixed income in retirement, for example, since it’s unlikely there’d be room in their budget to accommodate potentially higher monthly payments in the future, he said. More

  • in

    FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

    The Food and Drug Administration approved Johnson & Johnson’s nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. 
    The spray, called Spravato, is now the first-ever stand-alone therapy for treatment-resistant depression, which is when trying at least two standard treatments does little to nothing to improve depression symptoms in a patient. 
    Spravato is on its way to becoming a blockbuster product, with the drug bringing in $780 million in sales during the first nine months of 2024 as doctors grow more comfortable using it.

    This photo provided by Janssen Global Services shows Spravato nasal spray.
    Janssen Global Services via AP

    The Food and Drug Administration on Tuesday approved Johnson & Johnson’s nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. 
    The spray, called Spravato, is now the first-ever stand-alone therapy for treatment-resistant depression, which is when trying at least two standard treatments does little to nothing to improve depression symptoms in a patient. 

    Previously, Spravato was cleared in the U.S. to use together with an oral antidepressant for both treatment-resistant depression and for people with major depressive disorder who are experiencing thoughts of suicide or harm. The drug first entered the U.S. market in 2019. 
    “We want to recognize that this is a medicine that treats a disease that [when] left untreated, depression is potentially fatal,” Bill Martin, J&J’s global therapeutic area head of neuroscience, said in an interview. 
    Around one-third of the estimated 21 million U.S. adults with major depression battle symptoms — such as persistent feelings of sadness, sleep disturbances, low energy, and thoughts of death or suicide — that don’t respond to treatment, according to some estimates. 
    “For the first time ever, we now have an option that gives patients freedom,” said Dr. Gregory Mattingly, a physician and president of the Midwest Research Group who was involved in Spravato’s original clinical trials. 
    His center in St. Louis has treated more than 6,000 patients with the drug, and currently just over 100 people are taking it there. That is one of 3,000 outpatient treatment centers in the U.S. that are certified to administer Spravato, according to J&J’s tally.

    Mattingly said patients can now choose to take Spravato with or without an oral antidepressant, especially if those pills aren’t improving their symptoms and are causing undesirable side effects, such as weight gain and sexual issues. 
    J&J’s Martin said the approval provides “an avenue for caregivers and their patients to really optimize, personalize the treatment paradigm for each individual” and determine the best way for them to manage the disease. 
    That could potentially “open up the number of patients who could benefit” from Spravato, according to Martin. 

    More CNBC health coverage

    Spravato is on its way to becoming a blockbuster product, with the drug bringing in $780 million in sales during the first nine months of 2024 as doctors grow more comfortable using it, according to J&J’s third-quarter earnings. The company has even higher expectations for its growth, telling investors in December that it expects sales will increase to between $1 billion and $5 billion annually. 
    That is a boon to J&J as it prepares for an upcoming patent expiration and new negotiated prices with Medicare to pressure sales of its top-selling inflammatory treatment, Stelara. 
    The approval is based on a phase four trial, which showed Spravato alone improved depressive symptoms beginning about 24 hours after treatment and lasting through at least one month. The company has said that the safety profile was consistent with previous clinical data on Spravato’s use in combination with oral antidepressants.
    Martin said that demonstrates “not only rapid symptom relief, but also a durable symptom relief” when patients take Spravato by itself. 

    Spravato’s long road to rapid growth

    Spravato blazed a trail in 2019 as the first new major depression treatment to win FDA approval in more than three decades. The drug is related to ketamine, a common anesthetic that can have hallucinogenic effects and is sometimes misused recreationally. J&J made it into a nasal spray to get it into the brain quickly. 
    Spravato “turns on neural networks in a way that’s different,” said Mattingly. 
    “Our standard oral antidepressants took weeks to months to see if they’re going to work,” he added. “Quite often with the same day, the very next day, people can already start to feel they’re feeling somewhat better” with Spravato.
    Spravato’s warning label cautions about the risk of sedation and dissociation, respiratory depression, suicidal thoughts, and abuse or misuse of the drug, among other potential side effects. Because of that, Spravato is only available through a restricted program, meaning it can’t be purchased at a pharmacy and is only administered in certified health-care settings under strict supervision. 
    Users of the medication must also be monitored by a health-care professional for two hours following administration.
    Spravato’s launch had a sluggish start, especially as pandemic-related challenges complicated arrangements for the drug’s necessary medical supervision. But J&J began to market Spravato more heavily after in-person doctor visits became the norm again, and physicians became more aware of its benefits. 
    “The mental health community wasn’t really used to doing procedures at that point. We weren’t used to having a space set aside. We weren’t used to thinking about how to do Spravato,” Mattingly said. “I think the good news is now we’ve all seen the benefits to our patients. So many of us have become really strong advocates” for it. 
    Five years of real-world data on the drug and a head-to-head study demonstrating Spravato’s superior efficacy to an oral antidepressant also gave doctors higher confidence in the treatment, according to J&J’s Martin.
    If you are having suicidal thoughts or are in distress, contact the Suicide & Crisis Lifeline at 988 for support and assistance from a trained counselor.

    Don’t miss these insights from CNBC PRO More

  • in

    ‘Moana 2’ tops $1 billion, extending Disney’s box office domination

    Walt Disney Animation’s “Moana 2” has crossed $1 billion at the global box office.
    It is the third Disney film released in 2024 to reach this coveted benchmark.
    Disney now has 32 billion-dollar movies — including three films it acquired when it bought Fox in 2019.

    Dwayne Johnson voices Maui in Disney Animation’s “Moana 2.”

    The Walt Disney Company’s box office domination continued over the holiday weekend.
    “Moana 2” topped $1 billion during the Martin Luther King Jr. Day weekend, becoming the studio’s third 2024 release to reach the coveted benchmark after Marvel Studios’ “Deadpool and Wolverine” and Pixar’s “Inside Out 2.” No other Hollywood studio had a film cross $1 billion last year.

    “Moana 2” snared $442.8 million at the domestic box office and $567.1 million in international markets, the company posted over the weekend. It is the fourth film from the Walt Disney Animation arm to surpass $1 billion in ticket sales alongside “Frozen,” “Frozen II” and “Zootopia.”
    This feat is another feather in the cap for Disney, which had struggled in the years after the pandemic to gain tractions with its animated releases. Much of the company’s difficulties stemmed, in part, from decisions to debut a handful of animated features directly on its streaming service Disney+. This trained parents to look for new content at home even after theatrical closures ended and films returned to cinemas.
    “Inside Out 2” not only marked a return to form for Disney, but it helped jumpstart the overall domestic box office in June. It snared more than $650 million domestically and became the first film since Warner Bros′ “Barbie” to top $1 billion at the global box office.
    It also marked the first time a Pixar or Walt Disney Animation film generated more than $480 million at the global box office since 2019. “Inside Out 2″ ultimately became the highest-grossing film of 2024.
    “Deadpool and Wolverine,” “Inside Out 2” and “Moana 2,” along with a handful of other theatrical releases, helped Disney reach more than $2.2 billion at the domestic box office last year, accounting for about 25% of the industry’s total haul, according to data from Comscore.
    With “Moana 2” crossing the billion-dollar mark, Disney now has 32 billion-dollar movies — including three films it acquired when it bought Fox in 2019, according to the company. For context, there have only been 56 films that have topped $1 billion at the global box office, meaning Disney is responsible for nearly 60% of the highest-grossing films in cinematic history. More